Compare VERA & ICFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | ICFI |
|---|---|---|
| Founded | 2016 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2021 | 2006 |
| Metric | VERA | ICFI |
|---|---|---|
| Price | $29.79 | $94.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | $74.20 | ★ $107.25 |
| AVG Volume (30 Days) | ★ 1.6M | 134.3K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 0.59% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.61 |
| Revenue | N/A | ★ $1,229,162,000.00 |
| Revenue This Year | N/A | $1.68 |
| Revenue Next Year | $841.44 | $5.88 |
| P/E Ratio | ★ N/A | $36.45 |
| Revenue Growth | N/A | ★ 3.72 |
| 52 Week Low | $23.05 | $58.83 |
| 52 Week High | $56.05 | $98.03 |
| Indicator | VERA | ICFI |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 71.08 |
| Support Level | $26.38 | $82.23 |
| Resistance Level | $36.95 | $96.85 |
| Average True Range (ATR) | 1.58 | 2.40 |
| MACD | 0.19 | 0.99 |
| Stochastic Oscillator | 58.65 | 85.68 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.